Thyrotoxicosis: Diagnosis and Management.

Thyrotoxicosis is the clinical manifestation of excess thyroid hormone action at the tissue level due to inappropriately high circulating thyroid hormone concentrations. Hyperthyroidism, a subset of thyrotoxicosis, refers specifically to excess thyroid hormone synthesis and secretion by the thyroid gland. We performed a review of the literature on these topics utilizing published data in PubMed and MEDLINE. In this review, we discuss the more common etiologies of thyrotoxicosis, focusing on the current approach to diagnosis and management, new trends in those directions, and potential upcoming changes in the field.

• Publication year

  2019

• Venue

  Mayo Clinic proceedings

• Publication date

  2019-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.mayocp.2018.10.011PMID 30922695
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Case of Functional Metastatic Follicular Thyroid Carcinoma that Presented with Hip Fracture and Hypercalcemia

  2018cited by this paper
• Interpretation for surgical section of 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis

  2018cited by this paper
• Antithyroid Drugs and Congenital Malformations

  2018cited by this paper
• DIAGNOSIS OF ENDOCRINE DISEASE: Diagnostic approach to TSH-producing pituitary adenoma.

  2017cited by this paper
• Long-Term Antithyroid Drug Treatment: A Systematic Review and Meta-Analysis

  2017cited by this paper
• Graves' Disease.

  2017cited by this paper
• Biotin-Induced Biochemical Graves Disease: A Teachable Moment.

  2017cited by this paper
• Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study

  2017cited by this paper
• Evaluation of 99mTc-MIBI in thyroid gland imaging for the diagnosis of amiodarone-induced thyrotoxicosis.

  2017cited by this paper
• Thyroid abnormalities following the use of cytotoxic T‐lymphocyte antigen‐4 and programmed death receptor protein‐1 inhibitors in the treatment of melanoma

  2017cited by this paper
• Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms

  2017cited by this paper
• A case of metastatic follicular thyroid carcinoma complicated with Graves' disease after total thyroidectomy.

  2017cited by this paper
• Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis

  2017cited by this paper
• Antithyroid Drug Side Effects in the Population and in Pregnancy.

  2016cited by this paper
• Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab

  2016cited by this paper
• Biotin Treatment Mimicking Graves' Disease.

  2016cited by this paper
• Hypothyroidism Following Hemithyroidectomy: Incidence, Risk Factors, and Clinical Characteristics.

  2016cited by this paper
• Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management

  2016cited by this paper
• Antithyroid Drugs—The Most Common Treatment for Graves' Disease in the United States: A Nationwide Population-Based Study

  2016cited by this paper
• A 2013 European survey of clinical practice patterns in the management of Graves' disease

  2016cited by this paper
• Rapid Control of T3 Thyrotoxicosis in Patients with Metastatic Follicular Thyroid Cancer Treated with Lenvatinib

  2015cited by this paper
• Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and bayesian network meta-analysis.

  2015cited by this paper
• Role of genetic and non-genetic factors in the etiology of Graves’ disease

  2015cited by this paper
• Iodine deficiency and thyroid disorders.

  2015cited by this paper
• Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment

  2015cited by this paper
• Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiation.

  2014cited by this paper
• The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type.

  2014cited by this paper
• Block & replace regime versus titration regime of antithyroid drugs for the treatment of Graves’ disease: a retrospective observational study

  2014cited by this paper
• Severity of Birth Defects After Propylthiouracil Exposure in Early Pregnancy

  2014cited by this paper
• Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.

  2014cited by this paper
• Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.

  2014cited by this paper
• Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics.

  2014cited by this paper
• Preventing Postoperative Hypocalcemia in Patients with Graves Disease: A Prospective Study

  2014cited by this paper
• The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.

  2014cited by this paper
• Thyroxine and Triiodothyronine Content in Commercially Available Thyroid Health Supplements

  2013cited by this paper
• Use of Color Doppler Ultrasonography to Measure Thyroid Blood Flow and Differentiate Graves' Disease from Painless Thyroiditis

  2013cited by this paper
• Tyrosine Kinase Inhibitors Induced Thyroid Dysfunction: A Review of Its Incidence, Pathophysiology, Clinical Relevance, and Treatment

  2013cited by this paper
• Incidence rate of symptomatic painless thyroiditis presenting with thyrotoxicosis in Denmark as evaluated by consecutive thyroid scintigraphies

  2013cited by this paper
• Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis.

  2013cited by this paper
• TSH suppression after intravenous glucocorticosteroid administration in preterm infants

  2012cited by this paper
• Hepatotoxicity and cutaneous reactions after antithyroid drug administration

  2012cited by this paper
• Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction.

  2012cited by this paper
• TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis.

  2012cited by this paper
• Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies.

  2012cited by this paper
• A 2011 survey of clinical practice patterns in the management of Graves' disease.

  2012cited by this paper
• Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease

  2011cited by this paper
• Sustained Control of Graves' Hyperthyroidism During Long-Term Low-Dose Antithyroid Drug Therapy of Patients with Severe Graves' Orbitopathy

  2011cited by this paper
• Outcome of Very Long-Term Treatment with Antithyroid Drugs in Graves' Hyperthyroidism Associated with Graves' Orbitopathy

  2011cited by this paper
• Treatment of autonomously functioning thyroid nodules at a single institution: radioiodine therapy, surgery, and ethanol injection therapy

  2011cited by this paper
• Thyroid dermopathy and acropachy.

  2011cited by this paper
• 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum

  2011cited by this paper
• Incidence of hyperthyroidism in Sweden.

  2011cited by this paper
• Approach to the patient with amiodarone-induced thyrotoxicosis.

  2010cited by this paper
• Fractionated Radioiodine Therapy for Hyperthyroidism Caused by Widespread Metastatic Follicular Thyroid Carcinoma

  2010cited by this paper
• Incidence of pituitary adenomas in Northern Finland in 1992-2007.

  2010cited by this paper
• eview enetics of thyroid autoimmunity and the role of the TSHR

  2010cited by this paper
• Hyperfunctioning thyroid cancer: a five-year follow-up.

  2010cited by this paper
• Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors.

  2010cited by this paper
• Antithyroid drug regimen for treating Graves' hyperthyroidism.

  2010cited by this paper
• Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review.

  2009cited by this paper
• The Role of Propylthiouracil in the Management of Graves' Disease in Adults: Report of a Meeting Jointly Sponsored by the American Thyroid Association and the Food and Drug Administration

  2009cited by this paper
• 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

  2009cited by this paper
• Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib.

  2008cited by this paper
• Long-term follow-up of patients with hyperthyroidism due to Graves’ disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: A retrospective study

  2008cited by this paper
• 3,5,3'-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma.

  2008cited by this paper
• The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.

  2008cited by this paper
• Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.

  2007cited by this paper
• Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: a possible marker for predicting long-term response to octreotide therapy.

  2007cited by this paper
• The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies.

  2007cited by this paper
• Proportion of type 1 and type 2 amiodarone‐induced thyrotoxicosis has changed over a 27‐year period in Italy

  2007cited by this paper
• A practical guide for clinicians who treat patients with amiodarone: 2007.

  2007cited by this paper
• B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study.

  2007cited by this paper
• Hypothyroidism after Sunitinib Treatment for Patients with Gastrointestinal Stromal Tumors

  2006cited by this paper
• Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype.

  2006cited by this paper
• Serum Thyrotropin Receptor Antibodies Concentrations in Patients with Graves' Disease Before, at the End of Methimazole Treatment, and After Drug Withdrawal: Evidence That the Activity of Thyrotropin Receptor Antibody and/or Thyroid Response Modify During the Observation Period

  2006cited by this paper
• Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus.

  2005cited by this paper
• Outcome of radioiodine‐131 therapy in hyperfunctioning thyroid nodules: a 20 years’ retrospective study

  2005cited by this paper
• Thyrotoxicosis caused by weight-reducing herbal medicines.

  2005cited by this paper
• Graves' Disease: A Long-Term Quality-of-Life Follow Up of Patients Randomized to Treatment with Antithyroid Drugs, Radioiodine, or Surgery

  2005cited by this paper
• Surgical Management of Amiodarone-associated Thyrotoxicosis: Mayo Clinic Experience

  2004cited by this paper
• Radioiodine or Surgery for Toxic Thyroid Adenoma: Dissecting an Important Decision. A Cost-Effectiveness Analysis

  2004cited by this paper
• Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis

  2003cited by this paper
• Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy.

  2003cited by this paper
• Antithyroid drug regimen for treating Graves' hyperthyroidism.

  2003cited by this paper
• Perioperative management of the thyrotoxic patient.

  2003cited by this paper
• Graves’ Disease 1835–2002

  2003cited by this paper
• Does smoking increase relapse rates in Graves’ disease?

  2002cited by this paper
• Current treatment of nodular goiter with hyperthyroidism (Plummer's disease): surgery versus radioiodine.

  2002cited by this paper
• Managing toxic thyroid adenoma: a cost-effectiveness analysis.

  2002cited by this paper
• Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

  2002cited by this paper
• TSH‐receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays

  2001cited by this paper
• Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care.

  2001cited by this paper
• Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts.

  2001cited by this paper
• Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.

  2001cited by this paper
• Environmental Iodine Intake Affects the Type of Nonmalignant Thyroid Disease

  2001cited by this paper
• Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity.

  2000cited by this paper
• Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.

  2000cited by this paper
• Age and gender predict the outcome of treatment for Graves' hyperthyroidism.

  2000cited by this paper
• HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective.

  1999cited by this paper
• Long‐term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules

  1999cited by this paper

• Xenobiotic modalities impacting the thyroid 3H framework of hormonogenesis, homeostasis, and human health.

  2026cites this paper
• Marine-Lenhart syndrome: a comprehensive literature review on diagnosis and management with emphasis on nuclear medicine approach.

  2025cites this paper
• Thyroid Disorders During Pregnancy

  2025cites this paper
• Hyperthyroidism and Thyrotoxicosis

  2025cites this paper
• Autoimmune Diseases and Pregnancy – Is There a Greater Risk of Giving Birth to a Sick Child?

  2025cites this paper
• Evaluation of Potential Hormonal Activities of Ashwagandha (Withania somnifera).

  2025cites this paper
• Wernicke’s Encephalopathy in hyperthyroidism and thyrotoxicosis: a systematic review

  2025cites this paper
• CORRELATION OF TPO ANTIBODY CONCENTRATION WITH THYROID HORMONES AS A PREDICTOR OF CLINICAL HYPOTHYROIDISM

  2024cites this paper
• PREDICTORS OF TSH NORMALIZATION IN THYROTOXICOSIS PATIENTS AFTER TREATMENT.

  2024cites this paper
• Tormenta tiroidea: abordaje diagnóstico y terapéutico

  2024cites this paper
• Prenatal double-hit with aluminium and cadmium mediate testicular atrophy and hypothalamic hypoplasia: the role of oxido-nitrergic stress and endocrine perturbations

  2024cites this paper
• Genetic predisposition to thyrotoxicosis and onset of knee osteoarthritis

  2024cites this paper
• The Causes of Thyrotoxicosis, Clinical Features, and Treatment Strategies in a Former Iodine Deficient Area

  2024cites this paper
• Kardiomiopati Tirotoksikosis

  2024cites this paper
• Deep Learning Analysis with Gray Scale and Doppler Ultrasonography Images to Differentiate Graves' Disease.

  2024cites this paper
• Graves’ disease post-COVID-19 m-RNA vaccine in pediatric age group

  2024cites this paper
• Hemodynamic Melody of Postnatal Cardiac and Pulmonary Development in Children with Congenital Heart Diseases

  2024cites this paper
• Plasmapheresis in thyrotoxicosis: a single-center case series

  2024cites this paper
• When Liver Disease Coincides With Heart Failure: A Diagnostic Case Challenge

  2024cites this paper
• Evaluation of the prevalence and laboratory test results of overt thyrotoxicosis cases

  2024cites this paper
• Reasons for Referring Patients for Determining the Hormonal Status of the Thyroid Gland From the Level of Primary Health Care in Sarajevo Canton

  2024cites this paper
• Painless Thyroiditis by Withania somnifera (Ashwagandha)

  2024cites this paper
• High Diagnostic Accuracy of Thyroid-Stimulating Hormone (TSH) Receptor Antibodies in Distinguishing Graves’ Disease and Subacute Thyrotoxicosis in the Indian Population

  2024cites this paper
• Comparison of agranulocytosis and anti‐neutrophil cytoplasmic antibody‐associated vasculitis caused by two antithyroid drugs: A pharmacovigilance study using the WHO international database

  2024cites this paper
• Using Bedside Spectral Doppler Ultrasound for the Assessment of Patients with Thyrotoxicosis.

  2024cites this paper
• Trends in thyrotoxicosis-related mortality in the United States from 1999 to 2020

  2024cites this paper
• Dilated Cardiomyopathy Related to Hyperthyroidism in Young Adults

  2024cites this paper
• REVIEW OF SARS-CORONAVIRUS-2 REPERCUSSIONS ON THYROID GLAND IN THE CONTEXT OF HYPERTHYROIDISM

  2023cites this paper
• Propranolol-induced Pancreatitis After Treatment for Graves' Disease in an Adult With Type 1 Diabetes.

  2023cites this paper
• Acute effect of propranolol on resting energy expenditure in hyperthyroid patients

  2023cites this paper
• Thyrotoxicosis-Induced Cardiomyopathy With Systolic Dysfunction

  2023cites this paper
• Thyroid hormone triiodothyronine does not protect ovarian reserve from DNA damage induced by X-ray and cisplatin

  2023cites this paper
• Safety of oral propranolol for neonates with problematic infantile hemangioma: a retrospective study in an Asian population

  2023cites this paper
• The role of amiodarone in post-operative hypothyroidism patient with factitious thyrotoxicosis and atrial fibrillation: A case report

  2023cites this paper
• Acute suppurative thyroiditis with Graves disease – A very rare association

  2023cites this paper
• Long‐term survival in a dog with probable thyroid storm

  2023cites this paper
• Thyrotoxic Cardiomyopathy: State of the Art

  2023cites this paper
• The value of FT4/TSH ratio in the differential diagnosis of Graves’ disease and subacute thyroiditis

  2023cites this paper
• Preoperative preparation for Graves’ disease

  2023cites this paper
• [Type 1 diabetes mellitus is likely to increase the risk of thyrotoxicdsis: a two-sample Mendelian randomization study].

  2023cites this paper
• Approach to amiodarone induced thyroid storm: A case report

  2023cites this paper
• OPTIMIZATION OF COMPLEX THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION АND THYROTOXIC CARDIOMYOPATHY

  2023cites this paper
• Cut-Off Value of Thyrotropin-Receptor Antibodies in Grave’s Disease in Basrah

  2023cites this paper
• Case Report of Graves' Disease in a 45-Year-Old Woman Secondary to Herceptin Treatment for Breast Cancer

  2023influential citation
• A CASE REPORT OF HAND AND FOOT SKIN CHANGES RESEMBLING PTU-INDUCED VASCULITIS IN A YOUNG MALE WITH DIFFUSE TOXIC GOITRE.

  2023cites this paper
• An Effective Straightforward Protocol for the Treatment of Graves' Hyperthyroidism for Primary Care Providers.

  2023cites this paper
• Use of thyroid stimulating hormone receptor antibodies test in an outpatient endocrinology clinic for differential diagnosis of hyperthyroidism

  2022cites this paper
• Implications and Practical Applications of the Chemical Speciation of Iodine in the Biological Context

  2022cites this paper
• Impending tyroid storm

  2022cites this paper
• SPECIFIC COMPLICATIONS OF GOITER SURGERY AND WAYS TO PREVENT THEM

  2022cites this paper
• Perioperative management of the thyrotoxic patients: A systematic review

  2022cites this paper
• Thyrotoxicosis in Africa: a systematic review and meta-analysis of the clinical presentation

  2022cites this paper
• Graves-Basedow disease treated by complementary medicine leading to severe thyrotoxicosis – a case report

  2022cites this paper
• Utility of TSH Receptor Antibodies in the Differential Diagnosis of Hyperthyroidism in Clinical Practice

  2022cites this paper
• Serum DIT: A Possible Novel Biomarker to Distinguish Destructive Thyroiditis from Graves’ Disease

  2022cites this paper
• Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines.

  2022cites this paper
• fT3 index/TSH index ratio and free thyroid hormone index in the differential diagnosis of thyrotoxicosis

  2022cites this paper
• Patient outcomes following thyroid surgery for thyrotoxicosis

  2022cites this paper
• Sick sinus syndrome and hyperthyroidism: A rare phenomenon

  2021cites this paper
• Medical treatment of thyrotoxicosis.

  2021cites this paper
• Type 2 Marine-Lenhart Syndrome: An Uncommon Cause of Thyrotoxicosis

  2021influential citation
• Scrutinizing the therapeutic and diagnostic potential of nanotechnology in thyroid cancer: Edifying drug targeting by nano-oncotherapeutics

  2021cites this paper
• Automatic differentiation of thyroid scintigram by deep convolutional neural network: a dual center study

  2021cites this paper
• Disorders of the Thyroid and Parathyroid

  2021cites this paper
• Hyperthyroïdie

  2021cites this paper
• Beneficial Extracardiac Effects of Cardiovascular Medications

  2021cites this paper
• Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease

  2021cites this paper
• Rapid Differential Diagnosis of Thyrotoxicosis Using T3/T4 Ratio, FT3/FT4 Ratio and Color Doppler of Thyroid Gland

  2021cites this paper
• Management of Pediatric Graves Disease: A Review.

  2021cites this paper
• Sepsis and thyroid storm in a patient with methimazole-induced agranulocytosis

  2020cites this paper
• Topical L‐thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?

  2020cites this paper
• Rhabdomyolysis in a Patient with Severe Hypothyroidism: A Case Report

  2020influential citation
• Deep Convolution Neural Network Based Artificial Intelligence Improves Diagnosis of Thyroid Scintigraphy for Thyrotoxicosis: a Dual Center Study

  2020cites this paper
• Interpretation of Thyroid Function Tests

  year unknowncites this paper